Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 248420, 9 pages
http://dx.doi.org/10.1155/2014/248420
Review Article

Pulmonary Rehabilitation: The Reference Therapy for Undernourished Patients with Chronic Obstructive Pulmonary Disease

1Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland
2Nutrition Unit, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211 Geneva 14, Switzerland
3Explorations Fonctionnelles, Hôpital G et R Laennec, Boulevard Jacques Monod, 44093 Nantes Cedex 1, France

Received 18 October 2013; Revised 7 January 2014; Accepted 16 January 2014; Published 19 February 2014

Academic Editor: Wim Janssens

Copyright © 2014 Nikolaos Samaras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Kim and G. J. Criner, “Chronic bronchitis and chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 3, pp. 228–237, 2013. View at Google Scholar
  2. D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman et al., “Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable,” Proceedings of the American Thoracic Society, vol. 4, no. 2, pp. 145–168, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. E. O'Donnell, “Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease,” Proceedings of the American Thoracic Society, vol. 3, no. 2, pp. 180–184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Pitta, T. Troosters, M. A. Spruit, V. S. Probst, M. Decramer, and R. Gosselink, “Characteristics of physical activities in daily life in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 9, pp. 972–977, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Barnes and B. R. Celli, “Systemic manifestations and comorbidities of COPD,” European Respiratory Journal, vol. 33, no. 5, pp. 1165–1185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. Evans, J. E. Morley, J. Argilés et al., “Cachexia: a new definition,” Clinical Nutrition, vol. 27, no. 6, pp. 793–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. C. Creutzberg, A. M. W. J. Schols, F. C. M. Bothmer-Quaedvlieg, and E. F. M. Wouters, “Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function,” European Journal of Clinical Nutrition, vol. 52, no. 6, pp. 396–401, 1998. View at Google Scholar · View at Scopus
  8. A. M. W. J. Schols, P. B. Soeters, A. M. C. Dingemans, R. Mostert, P. J. Frantzen, and E. F. M. Wouters, “Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation,” American Review of Respiratory Disease, vol. 147, no. 5, pp. 1151–1156, 1993. View at Google Scholar · View at Scopus
  9. M. P. K. J. Engelen, A. M. W. J. Schols, W. C. Baken, G. J. Wesseling, and E. F. M. Wouters, “Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD,” European Respiratory Journal, vol. 7, no. 10, pp. 1793–1797, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. P. K. J. Engelen, A. M. W. J. Schols, R. J. S. Lamers, and E. F. M. Wouters, “Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease,” Clinical Nutrition, vol. 18, no. 5, pp. 275–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. I. Lewis, M. Fournier, T. W. Storer et al., “Skeletal muscle adaptations to testosterone and resistance training in men with COPD,” Journal of Applied Physiology, vol. 103, no. 4, pp. 1299–1310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. van Remoortel, M. Hornikx, H. Demeyer et al., “Daily physical activity in subjects with newly diagnosed COPD,” Thorax, vol. 68, no. 10, pp. 962–963, 2013. View at Google Scholar
  13. P. Palange, S. Forte, A. Felli, P. Galassetti, P. Serra, and S. Carlone, “Nutritional state and exercise tolerance in patients with COPD,” Chest, vol. 107, no. 5, pp. 1206–1212, 1995. View at Google Scholar · View at Scopus
  14. Y. Nishimura, M. Tsutsumi, H. Nakata, T. Tsunenari, H. Maeda, and M. Yokoyama, “Relationship between respiratory muscle strength and lean body mass in men with COPD,” Chest, vol. 107, no. 5, pp. 1232–1236, 1995. View at Google Scholar · View at Scopus
  15. R. Thibault, E. Le Gallic, M. Picard-Kossovsky, D. Darmaun, and A. Chambellan, “Assessment of nutritional status and body composition in patients with COPD: comparison of several methods,” Revue des Maladies Respiratoires, vol. 27, no. 7, pp. 693–702, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. M. W. J. Schols, J. Slangen, L. Volovics, and E. F. M. Wouters, “Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 6, pp. 1791–1797, 1998. View at Google Scholar · View at Scopus
  17. C. Landbo, E. Prescott, P. Lange, J. Vestbo, and T. P. Almdal, “Prognostic value of nutritional status in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1856–1861, 1999. View at Google Scholar · View at Scopus
  18. S. Marti, X. Muñoz, J. Rios, F. Morell, and J. J. Ferrer, “Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy,” European Respiratory Journal, vol. 27, no. 4, pp. 689–696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Gray-Donald, L. Gibbons, S. H. Shapiro, P. T. Macklem, and J. G. Martin, “Nutritional status and mortality in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 961–966, 1996. View at Google Scholar · View at Scopus
  20. K. Marquis, R. Debigaré, Y. Lacasse et al., “Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 6, pp. 809–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Slinde, A. M. Grönberg, C.-P. Engström, L. Rossander-Hulthén, and S. Larsson, “Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients,” Respiratory Medicine, vol. 99, no. 8, pp. 1004–1009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Chailleux, J.-P. Laaban, and D. Veale, “Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory,” Chest, vol. 123, no. 5, pp. 1460–1466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. N. J. M. Cano, C. Pichard, H. Roth et al., “C-reactive protein and body mass index predict outcome in end-stage respiratory failure,” Chest, vol. 126, no. 2, pp. 540–546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. W. J. Schols, R. Broekhuizen, C. A. Weling-Scheepers, and E. F. Wouters, “Body composition and mortality in chronic obstructive pulmonary disease,” American Journal of Clinical Nutrition, vol. 82, no. 1, pp. 53–59, 2005. View at Google Scholar · View at Scopus
  25. R. Casaburi, S. Bhasin, L. Cosentino et al., “Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 8, pp. 870–878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Svartberg, “Androgens and chronic obstructive pulmonary disease,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 17, no. 3, pp. 257–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Jemal, E. Ward, Y. Hao, and M. Thun, “Trends in the leading causes of death in the United States, 1970–2002,” Journal of the American Medical Association, vol. 294, no. 10, pp. 1255–1259, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. D. E. O'Donnell, J. C. Bertley, L. K. L. Chau, and K. A. Webb, “Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 1, pp. 109–115, 1997. View at Google Scholar · View at Scopus
  29. T. Geng, P. Li, X. Yin, and Z. Yan, “PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice,” American Journal of Pathology, vol. 178, no. 4, pp. 1738–1748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Jobin, F. Maltais, J.-F. Doyon et al., “Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle,” Journal of Cardiopulmonary Rehabilitation, vol. 18, no. 6, pp. 432–437, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Drexler, U. Riede, T. Munzel, H. Konig, E. Funke, and H. Just, “Alterations of skeletal muscle in chronic heart failure,” Circulation, vol. 85, no. 5, pp. 1751–1759, 1992. View at Google Scholar · View at Scopus
  32. D. P. Lipkin, D. A. Jones, J. M. Round, and P. A. Poole-Wilson, “Abnormalities of skeletal muscle in patients with chronic heart failure,” International Journal of Cardiology, vol. 18, no. 2, pp. 187–195, 1988. View at Google Scholar · View at Scopus
  33. F. Maltais, A.-A. Simard, C. Simard et al., “Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 1, pp. 288–293, 1996. View at Google Scholar · View at Scopus
  34. J. Sauleda, F. García-Palmer, R. J. Wiesner et al., “Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, part 1, pp. 1413–1417, 1998. View at Google Scholar · View at Scopus
  35. C. A. Raguso and C. Luthy, “Nutritional status in chronic obstructive pulmonary disease: role of hypoxia,” Nutrition, vol. 27, no. 2, pp. 138–143, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Dentener, E. C. Creutzberg, A. M. W. J. Schols et al., “Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations,” Thorax, vol. 56, no. 9, pp. 721–726, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Eid, A. A. Ionescu, L. S. Nixon et al., “Inflammatory response and body composition in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 8 I, pp. 1414–1418, 2001. View at Google Scholar · View at Scopus
  38. R. Debigaré, C. H. Côté, and F. Maltais, “Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 9, pp. 1712–1717, 2001. View at Google Scholar · View at Scopus
  39. M. A. P. Vermeeren, A. M. W. J. Schols, and E. F. M. Wouters, “Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD,” European Respiratory Journal, vol. 10, no. 10, pp. 2264–2269, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Li, R. E. Waters, S. I. Redfern et al., “Oxidative phenotype protects myofibers from pathological insults induced by chronic heart failure in mice,” American Journal of Pathology, vol. 170, no. 2, pp. 599–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Spruit, S. J. Singh, C. Garvey et al., “An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 8, pp. e13–e64, 2013. View at Google Scholar
  42. E. C. Creutzberg and R. Casaburi, “Endocrinological disturbances in chronic obstructive pulmonary disease,” European Respiratory Journal, Supplement, vol. 22, no. 46, pp. 76s–80s, 2003. View at Google Scholar · View at Scopus
  43. F. Laghi, A. Antonescu-Turcu, E. Collins et al., “Hypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of life,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 7, pp. 728–733, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Debigaré, K. Marquis, C. H. Côté et al., “Catabolic/anabolic balance and muscle wasting in patients with COPD,” Chest, vol. 124, no. 1, pp. 83–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Kamischke, D. E. Kemper, M. A. Castel et al., “Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy,” European Respiratory Journal, vol. 11, no. 1, pp. 41–45, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. F. C. W. Wu, A. Tajar, J. M. Beynon et al., “Identification of late-onset hypogonadism in middle-aged and elderly men,” The New England Journal of Medicine, vol. 363, no. 2, pp. 123–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Lapauw, S. Goemaere, H. Zmierczak et al., “The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes,” European Journal of Endocrinology, vol. 159, no. 4, pp. 459–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Samaras, D. Samaras, P. O. Lang et al., “A view of geriatrics through hormones,” Maturitas, 2012. View at Publisher · View at Google Scholar
  49. U. Aasebo, A. Gyltnes, R. M. Bremnes, A. Aakvaag, and L. Slordal, “Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 46, no. 6, pp. 799–803, 1993. View at Publisher · View at Google Scholar · View at Scopus
  50. T. van der Poll, J. A. Romijn, E. Endert, and H. P. Sauerwein, “Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men,” Metabolism, vol. 42, no. 3, pp. 303–307, 1993. View at Publisher · View at Google Scholar · View at Scopus
  51. F. R. Sattler, C. Castaneda-Sceppa, E. F. Binder et al., “Testosterone and growth hormone improve body composition and muscle performance in older men,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, pp. 1991–2001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Serra, S. Bhasin, F. Tangherlini et al., “The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle,” Endocrinology, vol. 152, no. 1, pp. 193–206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. T. W. Storer, L. Woodhouse, L. Magliano et al., “Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men,” Journal of the American Geriatrics Society, vol. 56, no. 11, pp. 1991–1999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Maggio, G. P. Ceda, F. Lauretani et al., “Gonadal status and physical performance in older men,” Aging Male, vol. 14, no. 1, pp. 42–47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. D. L. O'Connell, A. Tajar, S. A. Roberts, and F. C. W. Wu, “Do androgens play any role in the physical frailty of ageing men?” International Journal of Andrology, vol. 34, no. 3, pp. 195–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Van Vliet, M. A. Spruit, G. Verleden et al., “Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 9, pp. 1105–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. Z. Hyde, P. E. Norman, L. Flicker et al., “Low free testosterone predicts mortality from cardiovascular disease but not other causes: the health in men study,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 1, pp. 179–189, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Oettel, D. Hübler, and V. Patchev, “Selected aspects of endocrine pharmacology of the aging male,” Experimental Gerontology, vol. 38, no. 1-2, pp. 189–198, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Scalvini, “Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease,” Monaldi Archives for Chest Disease, vol. 51, no. 5, pp. 380–386, 1996. View at Google Scholar · View at Scopus
  60. A. Hjalmarsen, U. Aasebø, K. Birkeland, G. Sager, and R. Jorde, “Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease,” Diabetes and Metabolism, vol. 22, no. 1, pp. 37–42, 1996. View at Google Scholar · View at Scopus
  61. U. Srinivas-Shankar, S. A. Roberts, M. J. Connolly et al., “Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 639–650, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. M. H. Emmelot-Vonk, H. J. J. Verhaar, H. R. Nakhai Pour et al., “Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial,” Journal of the American Medical Association, vol. 299, no. 1, pp. 39–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Basaria, A. D. Coviello, T. G. Travison et al., “Adverse events associated with testosterone administration,” The New England Journal of Medicine, vol. 363, no. 2, pp. 109–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. K. J. Ottenbacher, M. E. Ottenbacher, A. J. Ottenbacher, A. A. Acha, and G. V. Ostir, “Androgen treatment and muscle strength in elderly men: a meta-analysis,” Journal of the American Geriatrics Society, vol. 54, no. 11, pp. 1666–1673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  65. T. G. Travison, S. Basaria, T. W. Storer et al., “Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation,” Journals of Gerontology A, vol. 66, no. 10, pp. 1090–1099, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. A. B. Araujo, T. G. Travison, S. Bhasin et al., “Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men,” Journal of the American Geriatrics Society, vol. 56, no. 11, pp. 2000–2008, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. M. S. Velema, B. H. B. Kwa, and W. De Ronde, “Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients?” Current Opinion in Pulmonary Medicine, vol. 18, no. 2, pp. 118–124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. S.-S. Yeh, B. DeGuzman, and T. Kramer, “Reversal of COPD-associated weight loss using the anabolic agent oxandrolone,” Chest, vol. 122, no. 2, pp. 421–428, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. J. Svartberg, U. Aaseboø, A. Hjalmarsen, J. Sundsfjord, and R. Jorde, “Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial,” Respiratory Medicine, vol. 98, no. 9, pp. 906–913, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. A. M. W. J. Schols, P. B. Soeters, R. Mostert, R. J. Pluymers, and E. F. M. Wouters, “Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, part 1, pp. 1268–1274, 1995. View at Google Scholar · View at Scopus
  71. I. M. Ferreira, I. T. Verreschi, L. E. Nery et al., “The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients,” Chest, vol. 114, no. 1, pp. 19–28, 1998. View at Google Scholar · View at Scopus
  72. C. M. Pison, N. J. Cano, C. Chérion et al., “Multimodal nutritional rehabilitation improves clinical outcomes of malnourished patients with chronic respiratory failure: a randomised controlled trial,” Thorax, vol. 66, no. 11, pp. 953–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. C. E. Bolton, E. F. Bevan-Smith, J. D. Blakey et al., “British Thoracic Society guideline on pulmonary rehabilitation in adults,” Thorax, 2013. View at Publisher · View at Google Scholar
  74. Y. Lacasse, S. Martin, T. J. Lasserson, and R. S. Goldstein, “Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease a Cochrane systematic review,” Europa Medicophysica, vol. 43, no. 4, pp. 475–485, 2007. View at Google Scholar · View at Scopus
  75. A. L. Ries, G. S. Bauldoff, B. W. Carlin et al., “Pulmonary rehabilitation: joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines,” Chest, vol. 131, no. 5, supplement, pp. 4S–42S, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. I. Vogiatzis, “Strategies of muscle training in very severe COPD patients,” European Respiratory Journal, vol. 38, no. 4, pp. 971–975, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. I. Vivodtzev, J.-L. Pépin, G. Vottero et al., “Improvement in quadriceps strenght and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD,” Chest, vol. 129, no. 6, pp. 1540–1548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. S. D. Anker and A. J. S. Coats, “Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation,” Chest, vol. 115, no. 3, pp. 836–847, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Lenk, R. Schur, A. Linke et al., “Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model,” European Journal of Heart Failure, vol. 11, no. 4, pp. 342–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Héliès-Toussaint, C. Moinard, C. Rasmusen, I. Tabbi-Anneni, L. Cynober, and A. Grynberg, “Aortic banding in rat as a model to investigate malnutrition associated with heart failure,” American Journal of Physiology, vol. 288, no. 5, pp. R1325–R1331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Guerrero, B. Wuyam, P. Mezin et al., “Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscle,” American Journal of Physiology, vol. 289, no. 4, pp. R1144–R1154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. E. C. H. van den Ham, J. P. Kooman, A. M. W. J. Schols et al., “The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients,” Transplantation, vol. 83, no. 8, pp. 1059–1068, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. N. Samaras, D. Samaras, P. O. Lang et al., “Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy,” Revue Médicale Suisse, vol. 8, no. 363, pp. 2224–2227, 2012. View at Google Scholar
  84. N. Samaras, E. Frangos, A. Forster, C. Graf, and D. Samaras, “Back pain: a case of ivory vertebrae and ribs,” European Geriatric Medicine, vol. 3, no. 3, pp. 184–185, 2012. View at Publisher · View at Google Scholar · View at Scopus